New Mexico's State Funded Approach to Gender-Affirming Healthcare

Facing federal regulatory changes, New Mexico plans to sustain gender-affirming healthcare for minors using state funds, sidestepping recent Medicaid restrictions.

Amid new federal regulations prohibiting the use of Medicaid and Children's Health Insurance Program (CHIP) funds for gender-affirming care for individuals under 19, New Mexico has taken decisive action. The state's Turquoise Care Medicaid program will continue coverage for necessary medications, excluding surgical procedures, to support minors' access to vital healthcare. This move aims to counteract a rule finalized by the Centers for Medicare and Medicaid Services and the U.S. Department of Health and Human Services, effective October 13, which restricts such funding.

Implications for Coverage and Access

The federal regulation raises significant concerns, particularly regarding puberty blockers, which are key in temporarily delaying puberty for transgender youth. Without insurance, the cost of these medications can range from $4,000 to $25,000 annually, creating a substantial financial barrier. Adrien Lawyer, Executive Director of the Transgender Resource Center of New Mexico, highlights the essential role insurance plays in making these treatments accessible. Despite the regulation, the state aims to mitigate its impact on approximately 4,800 transgender youths estimated to reside in New Mexico.

State and Industry Response

New Mexico's commitment to continuing coverage aligns with past actions by its Office of the Superintendent of Insurance, which declared in 2018 that coverage exclusion for gender dysphoria care violates state law. The recent federal changes echo previous decisions, such as the controversial 2025 exclusion of gender-affirming care from federal employee health programs, now under legal scrutiny for alleged discrimination. Insurance carriers, including Blue Cross Blue Shield of New Mexico and UnitedHealthcare, have also begun reevaluating coverage for related services, reflecting a broader trend of regulatory shifts.

Overview of Affected Populations

• 287,397 children enrolled in New Mexico's state Medicaid and CHIP programs as of July
• An estimated 4,800 transgender youth reside in New Mexico
• The regulation targets coverage for individuals under 19 for gender-affirming care

As New Mexico navigates this complex landscape, the insurance industry at large must pay close attention to evolving regulatory frameworks and their implications for coverage decisions and access to care. By sustaining coverage through state funds, New Mexico sets a precedent, balancing compliance with federal mandates and the ongoing healthcare needs of its communities. Industry professionals should closely monitor these trends and consider how federal and state policies might impact their operations and strategies moving forward.